The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up

Clinical diagnoses among individuals with primary age-related tauopathy versus Alzheimer’s neuropathology

(2019) Merilee Teylan et al.   LABORATORY INVESTIGATION

Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

(2019) Tiziana Carandini et al.   Alzheimers Research & Therapy

The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable

(2018) David S. Knopman et al.   Alzheimers & Dementia

The A/T/N biomarker scheme and patterns of brain atrophy assessed in mild cognitive impairment

(2018) Urban Ekman et al.   Scientific Reports

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

Suspected non-Alzheimer disease pathophysiology — concept and controversy

(2016) Clifford R. Jack et al.   Nature Reviews Neurology

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

(2016) Camilla Lauridsen et al.   Frontiers in Aging Neuroscience

PART is part of Alzheimer disease

(2015) Charles Duyckaerts et al.   ACTA NEUROPATHOLOGICA

Apolipoprotein E  2 genotype delays onset of dementia with Lewy bodies in a Norwegian cohort

(2014) G. Berge et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease

(2014) A. M. Fagan et al.   Science Translational Medicine

Pre-analytical factors influencing the stability of cerebrospinal fluid proteins

(2013) Anja H. Simonsen et al.   JOURNAL OF NEUROSCIENCE METHODS

Mild cognitive impairment—amyloid and beyond

(2013) Philip Scheltens   Nature Reviews Neurology

Aβ-independent processes—rethinking preclinical AD

(2013) Gaël Chételat   Nature Reviews Neurology

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Reisa A. Sperling et al.   Alzheimers & Dementia

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY